114 related articles for article (PubMed ID: 33978330)
41. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
42. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
43. [Mortality and re-admission after hospitalization with COVID-19].
Leijte WT; Wagemaker NMM; van Kraaij TDA; de Kruif MD; Mostard GJM; Leers MPG; Mostard RLM; Buijs J; van Twist DJL
Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33332036
[TBL] [Abstract][Full Text] [Related]
44. Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data.
Tanriverdİ E; Çörtük M; Yildirim BZ; Uğur Chousein EG; Turan D; Çinarka H; Özgül MA; Çetinkaya E
Turk J Med Sci; 2021 Feb; 51(1):10-5. PubMed ID: 32682360
[TBL] [Abstract][Full Text] [Related]
45. Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study.
UyaroĞlu OA; BaŞaran NÇ; ÖziŞik L; Dİzman GT; EroĞlu İ; Şahİn TK; TaŞ Z; İnkaya AÇ; TanriÖver MD; Metan G; GÜven GS; Ünal S
Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33104780
[TBL] [Abstract][Full Text] [Related]
46. Factors Affecting the Incidence, Progression, and Severity of COVID-19 in Type 1 Diabetes Mellitus.
Ahmed AS; Alotaibi WS; Aldubayan MA; Alhowail AH; Al-Najjar AH; Chigurupati S; Elgharabawy RM
Biomed Res Int; 2021; 2021():1676914. PubMed ID: 34840966
[TBL] [Abstract][Full Text] [Related]
47. Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
Li Y; Shang Y; Yang Y; Wang M; Yu D; Su D; Liu L; Wang Q; Zhang X; Ren J; Chen H
Respiration; 2020; 99(9):739-747. PubMed ID: 33207356
[TBL] [Abstract][Full Text] [Related]
48. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
49. Clinical and biochemical indexes of 11 COVID-19 patients and the genome sequence analysis of the tested SARS-CoV-2.
Yu Z; Wu H; Huang Q; Zhong Z
J Clin Lab Anal; 2021 Dec; 35(12):e24088. PubMed ID: 34741347
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics of 199 discharged patients with COVID-19 in Fujian Province: A multicenter retrospective study between January 22nd and February 27th, 2020.
Wang S; Chen Z; Lin Y; Lin L; Lin Q; Fang S; Shi Y; Zhuang X; Ye Y; Wang T; Zhang H; Shao C
PLoS One; 2020; 15(11):e0242307. PubMed ID: 33180862
[TBL] [Abstract][Full Text] [Related]
51. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
[TBL] [Abstract][Full Text] [Related]
52. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
[TBL] [Abstract][Full Text] [Related]
53. Predictors of mechanical ventilation for COVID-19: combined data from three designated hospitals.
Chen J; Zhu YF; Du ZQ; Li WF; Zhang MJ; Zhao SD; Ying JW; Li Z; Miao HJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13065-13071. PubMed ID: 33378060
[TBL] [Abstract][Full Text] [Related]
54. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
55. Analysis of factors for disease progression in 61 patients with COVID-19 in Xiaogan, Hubei, China.
Xing Y; Wang H; Yao XH; Li Y; Huang JT; Tang J; Zhu S; Liu YQ; Xiao J
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12490-12499. PubMed ID: 33336768
[TBL] [Abstract][Full Text] [Related]
56. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of prediction strategy and care coordination for COPD readmissions.
Bashir B; Schneider D; Naglak MC; Churilla TM; Adelsberger M
Hosp Pract (1995); 2016 Aug; 44(3):123-8. PubMed ID: 27391991
[TBL] [Abstract][Full Text] [Related]
58. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
Agbuduwe C; Basu S
Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study.
Boari GEM; Chiarini G; Bonetti S; Malerba P; Bianco G; Faustini C; Braglia-Orlandini F; Turini D; Guarinoni V; Saottini M; Viola S; Ferrari-Toninelli G; Pasini G; Mascadri C; Bonzi B; Desenzani P; Tusi C; Zanotti E; Nardin M; Rizzoni D
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33201172
[TBL] [Abstract][Full Text] [Related]
60. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever.
Liu CL; Lu YT; Peng MJ; Chen PJ; Lin RL; Wu CL; Kuo HT
Chest; 2004 Aug; 126(2):509-17. PubMed ID: 15302738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
